1 min to read News Posted on June 29, 2023 Biotech firm Tevogen Bio to go public in $1.2 billion SPAC deal – Nasdaq Biotech firm Tevogen Bio to go public in $1.2 billion SPAC deal Nasdaq Source: Biotech firm Tevogen Bio to go public in .2 billion SPAC deal – Nasdaq share share share